Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Fortuna Fix logo

Fortuna Fix

Recent Finacing

Series B

Recent Raise

$25M

Fortuna Fix is a clinical-stage regenerative medicine company developing a direct cell reprogramming platform (drNPC), RMx™ bio-scaffolds, and automated GMP production of drNPCs for spinal cord injury and Parkinson’s.

Founded 2015
England, United Kingdom
11-50
Private
fortunafix.com

Highlights

Focus Areas

Biotechnology
Medical
Medical Device
Pharmaceutical

Recent Investors

Amgen Ventures logo
S

Financials

$25M

Total Raised

1

Funding round

2

Investors